General
publicado em 26/04/2011 às 18h00:00
   Dê o seu voto:

Palivizumab will be used for preterm infants against respiratory infection

Medicine will be applied to premature babies and children under two years suffering from chronic lung disease

 
font size
A-
A+

Some pieces of information on this page may have been automatically translated. Makernews is not responsible for the irregularities resulting from these translations. When in doubt,      consult the original text.



The state Department of Health of Rio Grande do Sul shall distribute from the drug Palivizumab May, used to treat bronchiolitis, a disease caused by respiratory syncytial virus (RSV). The drug will be applied to premature babies and children under two years suffering from chronic lung disease, the Centers for Excellence in Special Immunobiologics (CREATE) of the Parthenon Sanatorium and Hospital Materno Infantil Presidente Vargas in Porto Alegre.

Initially, are also listed as a reference outpatient preterm infants discharged from hospitals in San Francisco de Paula Pelotas, University Hospital of Santa Maria General Hospital of Caxias do Sul, and Santa House Charities Bage.

There is possibility that this network be expanded from the activation of other outpatient services premature babies in Rio Grande do Sul The period of supply and application of palivizumab follows technical criteria defined by the length of seasonality of the virus in the state, which extends for the months from May to September. Each child can receive up to five doses (May-September) in the first year of life.

To receive immunizations, children must be registered for referral from the doctor who accompanied her, along with other documents required by the standard technique abril/2011 palivizumab.

France

Source: Isaude.net
   Palavras-chave:   Palivizumab    Respiratory infection    Rio Grande do Sul    Porto Alegre   
  • Share this pageShare this page
  • Share this pageCorrect
  • ShareShare
  • AlertAlert
Reduced link: 
  • You are recommending this story: Palivizumab will be used for preterm infants against respiratory infection
  • Fill in the following form to send your recommendation to your friend:

  • You are suggesting a correction for this story: Palivizumab will be used for preterm infants against respiratory infection


Receba notícias do iSaúde no seu e-mail de acordo com os assuntos de seu interesse.
Seu nome:
Seu email:
Desejo receber um alerta com estes assuntos:
Palivizumab    respiratory infection    Rio Grande do Sul    Porto Alegre   
Comments:
Comment
Leave your comment
Close
(Required fields are marked with an *)

(Your email address will never be published or shared.)

Enter the letters and numbers below and click in the button "send"

  • Twitter iSaúde
advertising
Informe Saúde printed version

Recommend the portal
Close [X]
  • You are recommending this story: http://www.isaude.net
  • Fill in the following form to send your recommendation to your friend:

RSS news from the portal  iSaúde.net
Get the newsletter of the portal  iSaúde.net
Recommend the portal iSaúde.net
News from  iSaúde.net in your blog or website.
Get news on the subject of your interest.
© 2000-2011 www.isaude.net Todos os direitos reservados.